Skip to main content Back to Top
Advertisement

11/14/2023

Amoxapine Tablets

Reason for the Shortage

    • Chartwell launched amoxapine tablets in late-2023.
    • Teva did not provide a reason for the shortage.

Available Products

    • Amoxapine oral tablet, Chartwell, 100 mg, bottle, 90 count, NDC 62135-0702-90
    • Amoxapine oral tablet, Chartwell, 150 mg, bottle, 30 count, NDC 62135-0703-30
    • Amoxapine oral tablet, Chartwell, 25 mg, bottle, 90 count, NDC 62135-0700-90
    • Amoxapine oral tablet, Chartwell, 50 mg, bottle, 90 count, NDC 62135-0701-90
    • Amoxapine oral tablet, Teva, 100 mg, bottle, 100 count, NDC 00591-5715-01
    • Amoxapine oral tablet, Teva, 150 mg, bottle, 30 count, NDC 00591-5716-30
    • Amoxapine oral tablet, Teva, 25 mg, bottle, 100 count, NDC 00591-5713-01
    • Amoxapine oral tablet, Teva, 50 mg, bottle, 100 count, NDC 00591-5714-01

Updated

Updated November 14, 2023 by Leslie Jensen, PharmD, Drug Information Specialist. Created December 15, 2017 by Leslie Jensen, PharmD, Drug Information Specialist. © 2023, Drug Information Service, University of Utah, Salt Lake City, UT.

ADVERTISEMENT

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins


ahfs logo

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.